专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US5523685A Method and apparatus for detecting penetrant metal and measuring thickness of refractory lining 失效
$Method and apparatus for detecting penetrant metal and measuring thickness of refractory lining$
标题翻译：检测渗透金属和测量耐火衬里厚度的方法和装置
公开(公告)号：US5523685A
公开(公告)日：1996-06-04
申请号：US14571
申请日：1993-02-08
申请人： Kiyoto Kasai , Akio Ishii , Keisuke Asano , Shiro Sukenari
发明人： Kiyoto Kasai , Akio Ishii , Keisuke Asano , Shiro Sukenari
IPC分类号： B22D35/04 , F27D21/00 , G01B7/287 , G01B7/06 , G01R33/12
CPC分类号： G01B7/287 , B22D35/04 , F27D21/0021
摘要： The present invention is a measuring method for detecting penetrant metal intruded in refractories having a conductive cover at a first wall and a nonconductive surface at a second wall and for measuring their thickness. At least one sensor head is used including a metal sensor with a first and second conductive coil for measuring distance between the sensor head and a conductive substance and a distance sensor for measuring distance between the sensor head and the refractories. The sensor head is disposed at a plurality of fixed positions close to the second wall to face the refractories and an alternating current is applied to the first coil to generate an eddy current in the conductive substance which faces the metal sensor. An induced voltage induced in the second coil by at least the eddy current is detected and a first distance is obtained between the sensor head and the conductive substance based on the detected induced voltage. The distance sensor measures a second distance between the sensor head and the second side wall at fixed positions and a third distance is obtained between the second side wall and the conductive substance. Also information is obtained about a relative position of the sensor head with respect to the molten metal vessel. A location and dimension of the penetrant metal and a thickness profile of the refractories is calculated based on the first, second and third distances and the relative position of the sensor head.
摘要翻译：本发明是用于检测侵入耐火材料的渗透金属的测量方法，该耐火材料在第一壁处具有导电盖，在第二壁处具有非导电表面并用于测量其厚度。使用至少一个传感器头，包括具有用于测量传感器头和导电物质之间的距离的第一和第二导电线圈的金属传感器和用于测量传感器头和耐火材料之间的距离的距离传感器。传感器头设置在靠近第二壁的多个固定位置以面对耐火材料，并且交流电被施加到第一线圈，以在与金属传感器相对的导电物质中产生涡流。检测到在第二线圈中感应出的感应电压至少为涡电流，并且基于检测到的感应电压在传感器头和导电物质之间获得第一距离。距离传感器在固定位置处测量传感器头和第二侧壁之间的第二距离，并且在第二侧壁和导电物质之间获得第三距离。还获得关于传感器头相对于熔融金属容器的相对位置的信息。基于第一，第二和第三距离以及传感器头的相对位置来计算渗透剂金属的位置和尺寸以及耐火材料的厚度轮廓。

2. 发明授权

US5525607A Xanthine compounds 失效
标题翻译：黄嘌呤化合物
公开(公告)号：US5525607A
公开(公告)日：1996-06-11
申请号：US63684
申请日：1993-05-20
申请人： Fumio Suzuki , Junichi Shimada , Akio Ishii , Tetsuji Ohno , Akira Karasawa , Kazuhiro Kubo , Hiromi Nonaka , Fumio Suzuki , Junichi Shimada , Akio Ishii , Tetsuji Ohno , Akira Karasawa , Kazuhiro Kubo , Hiromi Nonaka
发明人： Fumio Suzuki , Junichi Shimada , Akio Ishii , Tetsuji Ohno , Akira Karasawa , Kazuhiro Kubo , Hiromi Nonaka , Fumio Suzuki , Junichi Shimada , Akio Ishii , Tetsuji Ohno , Akira Karasawa , Kazuhiro Kubo , Hiromi Nonaka
IPC分类号： C07D473/06 , C07D473/08 , C07D473/20 , C07D473/22 , A61K31/52 , C07D473/00
CPC分类号： C07D473/06 , C07D473/08 , C07D473/20 , C07D473/22
摘要： Novel xanthine compounds represented by the following formula: ##STR1## wherein each of R.sup.1, R.sup.2 and R.sup.3 independently represents hydrogen or lower alkyl;each of X.sup.1 and X.sup.2 independently represents oxygen or sulfur; and Q represents: ##STR2## The compounds are useful as a diuretic, a renal-protecting agent and bronchodilator.
摘要翻译：由下式表示的新型黄嘌呤化合物：其中R 1，R 2和R 3各自独立地表示氢或低级烷基; X1和X2各自独立地表示氧或硫; Q表示：该化合物可用作利尿剂，肾保护剂和支气管扩张剂。

3. 发明申请

US20060139851A1 Solid electrolytic capacitor 有权
标题翻译：固体电解电容器
公开(公告)号：US20060139851A1
公开(公告)日：2006-06-29
申请号：US11294903
申请日：2005-12-05
申请人： Kazuhiro Higuchi , Akihiro Inoue , Akio Ishii , Kazuhiro Saegusa , Kazuhiro Hatanaka
发明人： Kazuhiro Higuchi , Akihiro Inoue , Akio Ishii , Kazuhiro Saegusa , Kazuhiro Hatanaka
IPC分类号： H01G9/00
CPC分类号： H01G9/025 , H01G9/055
摘要： There is a solid electrolytic capacitor having a low ESR characteristic. In accordance with the solid electrolytic capacitor using an capacitor element wherein solid electrolyte is formed, the post-etching void factor of the anode foil used for the capacitor element is set at not more than 51% or the post-etching void factor of the cathode foil used for the capacitor element is set at not more than 44%, so that an electrode foil increases in conductivity and decreases in resistivity, to thereby obtain, coupled with the solid electrolyte of a low resistivity, a solid electrolytic capacitor having a lower ESR characteristic.
摘要翻译：存在具有低ESR特性的固体电解电容器。根据使用其中形成固体电解质的电容器元件的固体电解电容器，将用于电容器元件的阳极箔的后蚀刻空隙率设定为不大于51％或阴极的后蚀刻空隙因子用于电容器元件的箔被设定为不超过44％，使得电极箔的电导率增加并且电阻率降低，从而获得与低电阻率的固体电解质耦合的具有较低ESR的固体电解电容器特性。

4. 发明授权

US5756735A Xanthine derivatives 失效
标题翻译：黄嘌呤衍生物
公开(公告)号：US5756735A
公开(公告)日：1998-05-26
申请号：US483159
申请日：1995-06-07
申请人： Fumio Suzuki , Akio Ishii , Hiromi Nonaka , Nobuo Kosaka , Shunji Ichikawa , Junichi Shimada
发明人： Fumio Suzuki , Akio Ishii , Hiromi Nonaka , Nobuo Kosaka , Shunji Ichikawa , Junichi Shimada
IPC分类号： C07D473/06
CPC分类号： C07D473/06
摘要： The present invention relates to novel xanthine derivatives of the formula (I) which are selectively antagonistic to an adenosine A.sub.2 receptor, and pharmaceutically acceptable salts thereof. Formula (I): ##STR1## In the formula, R.sup.1 and R.sup.2 are the same or different and each represents a hydrogen atom, a propyl group, a butyl group or an allyl group; R.sup.3 represents a hydrogen atom or a lower alkyl group; Y.sup.1 and Y.sup.2 are the same or different and each represents a hydrogen atom or a methyl group; and Z represents a substituted or unsubstituted phenyl group, a pyridyl group, an imidazolyl group, a furyl group or a thienyl group.
摘要翻译：本发明涉及对腺苷A2受体选择性拮抗的式（I）的新颖黄嘌呤衍生物及其药学上可接受的盐。式（I）：（I）式中，R 1和R 2相同或不同，表示氢原子，丙基，丁基或烯丙基; R3表示氢原子或低级烷基; Y1和Y2相同或不同，各自表示氢原子或甲基; Z表示取代或未取代的苯基，吡啶基，咪唑基，呋喃基或噻吩基。

5. 发明授权

US5302596A Tricyclic compounds as TXA.sub.2 antagonists 失效
标题翻译：三环化合物作为TXA2拮抗剂
公开(公告)号：US5302596A
公开(公告)日：1994-04-12
申请号：US980617
申请日：1992-11-23
申请人： Etsuo Oshima , Hiroyuki Obase , Akira Karasawa , Kazuhiro Kubo , Ichiro Miki , Akio Ishii
发明人： Etsuo Oshima , Hiroyuki Obase , Akira Karasawa , Kazuhiro Kubo , Ichiro Miki , Akio Ishii
IPC分类号： A61K31/19 , A61K31/00 , A61K31/41 , A61K31/415 , A61K31/44 , A61K31/443 , A61K31/4433 , A61K31/47 , A61K31/505 , A61P7/02 , A61P9/00 , A61P29/00 , A61P37/08 , A61P43/00 , C07C57/46 , C07C59/13 , C07C63/49 , C07C65/26 , C07C67/00 , C07C229/50 , C07C233/52 , C07C233/81 , C07C235/14 , C07C235/40 , C07C235/54 , C07C235/62 , C07C235/78 , C07C235/82 , C07C235/84 , C07C237/04 , C07C237/24 , C07C237/38 , C07C241/00 , C07C251/20 , C07C317/44 , C07C323/61 , C07D235/06 , C07D313/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D471/04 , C07D491/056 , C07D521/00 , A61K31/435 , C07D473/00
CPC分类号： C07D235/06 , C07D231/12 , C07D233/56 , C07D249/08 , C07D313/12 , C07D405/12 , C07D417/12 , C07D471/04 , Y10S514/824 , Y10S514/826
摘要： Novel tricyclic compound represented by formula ##STR1## possess a TXA.sub.2 biosynthesis inhibiting activity and/or a TXA.sub.2 receptor antagonizing activity, and are expected to have preventive and therapeutic effects on ischemic diseases, cerebro-vascular diseases, etc.
摘要翻译：由式（I）表示的新型三环化合物具有TXA2生物合成抑制活性和/或TXA2受体拮抗活性，预期对缺血性疾病，脑血管疾病等具有预防和治疗作用。

6. 发明授权

US5242931A Tricyclic compounds as TXA.sub.2 antagonists 失效
标题翻译：三环化合物作为TXA2拮抗剂
公开(公告)号：US5242931A
公开(公告)日：1993-09-07
申请号：US856296
申请日：1992-03-23
申请人： Etsuo Oshima , Hiroyuki Obase , Akira Karasawa , Kazuhiro Kubo , Ichiro Miki , Akio Ishii
发明人： Etsuo Oshima , Hiroyuki Obase , Akira Karasawa , Kazuhiro Kubo , Ichiro Miki , Akio Ishii
IPC分类号： C07D235/06 , C07D313/12 , C07D405/12 , C07D417/12 , C07D471/04 , C07D521/00
CPC分类号： C07D235/06 , C07D231/12 , C07D233/56 , C07D249/08 , C07D313/12 , C07D405/12 , C07D417/12 , C07D471/04
摘要： Novel Tricyclic compound represented by formula ##STR1## possess a TXA.sub.2 biosynthesis inhibiting act and/or a TXA.sub.2 receptor antagonizing activity, and are expected to have preventive and therapeutic effects on ischemic diseases, cerebro-vascular diseases, etc.
摘要翻译：由式（I）表示的新型三环化合物具有TXA2生物合成抑制作用和/或TXA2受体拮抗活性，预期对缺血性疾病，脑血管疾病等具有预防和治疗作用。

7. 发明授权

US4994463A Tricyclic thromboxane A.sub.2 antagonists 失效
标题翻译：三环血栓素A2拮抗剂
公开(公告)号：US4994463A
公开(公告)日：1991-02-19
申请号：US281545
申请日：1988-12-08
申请人： Etsuo Oshima , Hiroyuki Obase , Akira Karasawa , Kazuhiro Kubo , Ichiro Miki , Akio Ishii , Hidee Ishii , Kenji Ohmori
发明人： Etsuo Oshima , Hiroyuki Obase , Akira Karasawa , Kazuhiro Kubo , Ichiro Miki , Akio Ishii , Hidee Ishii , Kenji Ohmori
IPC分类号： C07D211/14 , C07D313/12 , C07D333/34 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D471/10
CPC分类号： C07D405/06 , C07D211/14 , C07D313/12 , C07D333/34 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D471/10
摘要： Novel tricyclic compounds having a TXA.sub.2 antagonizing activity represented by formula (I): ##STR1## possess a potent antagonizing action against thromboxane A.sub.2 and also an antiallergic and/or antihistaminic activity, and are expected to have preventive and therapeutic effects on ischemic diseases, cerebro-vascular diseases, etc.

8. 发明申请

US20120038689A1 Display Device and Illumination Control Method 审中-公开
标题翻译：显示设备和照明控制方法
公开(公告)号：US20120038689A1
公开(公告)日：2012-02-16
申请号：US13280118
申请日：2011-10-24
申请人： Akio Ishii
发明人： Akio Ishii
IPC分类号： G09G5/10
CPC分类号： H04N5/63
摘要： According to an aspect of the present invention, there is provided a display device including: a video display unit; a housing configured to accommodate the video display unit; an illumination device provided in the housing; a power indicator provided on the housing and having a first state and a second state, the first state indicating that a power status is OFF, the second state indicating that the power status is ON; and an illumination controller configured to control the illumination device to be turned ON at a different timing shifted from a timing when the power indicator is transitioned from the first state to the second state, when the power status is transitioned from OFF to ON.
摘要翻译：根据本发明的一个方面，提供了一种显示装置，包括：视频显示单元; 壳体，被配置为容纳所述视频显示单元; 设置在所述壳体中的照明装置; 设置在壳体上并具有第一状态和第二状态的电源指示器，指示电源状态为OFF的第一状态，指示电源状态为ON的第二状态; 以及照明控制器，被配置为当所述电源状态从OFF转换到ON时，以与从所述电源指示器从所述第一状态转换到所述第二状态的定时偏移的不同定时，控制所述照明装置接通。

9. 发明申请

US20070086098A1 Color wheel device and projector using the same 审中-公开
标题翻译：色轮装置和投影机使用相同
公开(公告)号：US20070086098A1
公开(公告)日：2007-04-19
申请号：US11546925
申请日：2006-10-12
申请人： Nobutoshi Sekiguchi , Satoshi Omi , Akio Ishii
发明人： Nobutoshi Sekiguchi , Satoshi Omi , Akio Ishii
IPC分类号： G02B7/00
CPC分类号： H04N9/3114 , G02B7/006 , G02B26/008 , G03B21/14 , G03B33/08
摘要： A color wheel device can set a desired display mode without using a complex mechanical apparatus. For example, a color wheel device 1 includes a first color wheel 10 having transmitting regions of W, R, G, B in a circumferential direction and rotated on an axis, a second color wheel 20 having transmitting regions of W, R, G, B in a circumferential direction and rotated at the same axis of the first color wheel, and selecting means for selecting a relative location between the first and second color wheels 10, 20. While the first and second color wheels are rotated, the light is entered into the first color wheel 10 and is outputted from the second color wheel 20.
摘要翻译：色轮装置可以在不使用复杂的机械装置的情况下设置期望的显示模式。例如，色轮装置1包括沿圆周方向具有W，R，G，B的透光区域并沿轴线旋转的第一色轮10，具有W，R，G的透射区域的第二色轮20， B，并且在第一色轮的同一轴线处旋转;以及选择装置，用于选择第一和第二色轮10,20之间的相对位置。当第一和第二色轮旋转时，光进入第一色轮10并从第二色轮20输出。

10. 发明授权

US5484920A Therapeutic agent for Parkinson's disease 失效
标题翻译：帕金森病治疗剂
公开(公告)号：US5484920A
公开(公告)日：1996-01-16
申请号：US133510
申请日：1993-10-07
申请人： Fumio Suzuki , Junichi Shimada , Nobuaki Koike , Joji Nakamura , Shizuo Shioazaki , Shunji Ichikawa , Akio Ishii , Hiromi Nonaka
发明人： Fumio Suzuki , Junichi Shimada , Nobuaki Koike , Joji Nakamura , Shizuo Shioazaki , Shunji Ichikawa , Akio Ishii , Hiromi Nonaka
IPC分类号： C07D473/06 , C07D473/08 , C07D473/12 , A61K31/52
CPC分类号： C07D473/08 , C07D473/06 , C07D473/12
摘要： Agents for the treatment of Parkinson's disease contain, as an active ingredient, a xanthine derivative or a pharmaceutically acceptable salt thereof. The xanthine derivative is represented by the formula: ##STR1## in which R.sup.1, R.sup.2 are R.sup.3 are independently hydrogen, lower alkyl, lower alkenyl, or lower alkynyl; and R.sup.4 represents cycloalkyl, --(CH.sub.2).sub.n --R.sup.5 (in which R.sup.5 represents substituted or unsubstituted aryl or a substituted or unsubstituted heterocyclic group; and n is an integer of 0 to 4), or ##STR2## in which Y.sup.1 and Y.sup.2 represent independently hydrogen, halogen, or lower alkyl; and Z represents substituted or unsubstituted aryl, ##STR3## in which R.sup.6 represents hydrogen, hydroxy, lower alkyl, lower alkoxy, halogen, nitro, or amino; and m represents an integer of 1 to 4, or a substituted or unsubstituted heterocyclic group; and X.sup.1 and X.sup.2 represent independently O or S.
摘要翻译：用于治疗帕金森病的药物含有作为活性成分的黄嘌呤衍生物或其药学上可接受的盐。黄嘌呤衍生物由下式表示：其中R 1，R 2为R 3独立地为氢，低级烷基，低级烯基或低级炔基; 并且R 4表示环烷基， - （CH 2）n -R 5（其中R 5表示取代或未取代的芳基或取代或未取代的杂环基; n为0至4的整数）或其中Y 1和Y 2表示独立地是氢，卤素或低级烷基; Z表示取代或未取代的芳基，其中R 6表示氢，羟基，低级烷基，低级烷氧基，卤素，硝基或氨基; m表示1〜4的整数，或取代或未取代的杂环基; X1和X2独立地表示O或S.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式